Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
29
pubmed:dateCreated
1999-8-19
pubmed:abstractText
TPR-MET, a transforming counterpart of the c-MET proto-oncogene detected in experimental and human cancer, results from fusion of the MET kinase domain with a dimerization motif encoded by TPR. In this rearrangement the exons encoding the Met extracellular, transmembrane and juxtamembrane domains are lost. The juxtamembrane domain has been suggested to be a regulatory region endowed with negative feedback control. To understand whether its absence is critical for the generation of the Tpr-Met transforming potential, we produced a chimeric molecule (Tpr-juxtaMet) with a conserved juxtamembrane domain. The presence of the domain (aa 962-1009) strongly inhibited Tpr-Met dependent cell transformation. Cell proliferation, anchorage-independent growth, motility and invasion were also impaired. The enzymatic behavior of Tpr-Met and Tpr-juxtaMet was the same, while Tpr-juxtaMet ability to associate cytoplasmic signal transducers and to elicit downstream signaling was severely impaired. These data indicate that the presence of the juxtamembrane domain counterbalances the Tpr-Met transforming potential and therefore the loss of the exon encoding the juxtamembrane domain is crucial in the generation of the active TPR-MET oncogene.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing, http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Calmodulin-Dependent..., http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary, http://linkedlifedata.com/resource/pubmed/chemical/GAB1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/GRB2 Adaptor Protein, http://linkedlifedata.com/resource/pubmed/chemical/GRB2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Gab1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Grb2 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion, http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0950-9232
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4275-81
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10435641-Adaptor Proteins, Signal Transducing, pubmed-meshheading:10435641-Animals, pubmed-meshheading:10435641-Calcium-Calmodulin-Dependent Protein Kinases, pubmed-meshheading:10435641-Cell Line, Transformed, pubmed-meshheading:10435641-Cell Transformation, Neoplastic, pubmed-meshheading:10435641-DNA, Complementary, pubmed-meshheading:10435641-Dimerization, pubmed-meshheading:10435641-Enzyme Activation, pubmed-meshheading:10435641-Exons, pubmed-meshheading:10435641-Feedback, pubmed-meshheading:10435641-Fibroblasts, pubmed-meshheading:10435641-GRB2 Adaptor Protein, pubmed-meshheading:10435641-Humans, pubmed-meshheading:10435641-Leucine Zippers, pubmed-meshheading:10435641-Oncogene Proteins, Fusion, pubmed-meshheading:10435641-Phosphoproteins, pubmed-meshheading:10435641-Phosphorylation, pubmed-meshheading:10435641-Protein Processing, Post-Translational, pubmed-meshheading:10435641-Protein Structure, Tertiary, pubmed-meshheading:10435641-Proteins, pubmed-meshheading:10435641-Rats, pubmed-meshheading:10435641-Rats, Inbred F344, pubmed-meshheading:10435641-Recombinant Fusion Proteins, pubmed-meshheading:10435641-Sequence Deletion, pubmed-meshheading:10435641-Signal Transduction, pubmed-meshheading:10435641-Structure-Activity Relationship, pubmed-meshheading:10435641-Transfection, pubmed-meshheading:10435641-Tumor Stem Cell Assay
pubmed:year
1999
pubmed:articleTitle
Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET.
pubmed:affiliation
Institute for Cancer Research and Treatment (IRCC), University of Torino School of Medicine, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't